245 related articles for article (PubMed ID: 31984657)
1. Serum Midkine is a clinical significant biomarker for colorectal cancer and associated with poor survival.
Kemper M; Hentschel W; Graß JK; Stüben BO; Konczalla L; Rawnaq T; Ghadban T; Izbicki JR; Reeh M
Cancer Med; 2020 Mar; 9(6):2010-2018. PubMed ID: 31984657
[TBL] [Abstract][Full Text] [Related]
2. Serum midkine as non-invasive biomarker for detection and prognosis of non-small cell lung cancer.
Stern L; Mueller E; Bellon E; Reeh M; Grotelueschen R; Guengoer C; Melling N; Goetz M; Perez DR; Izbicki JR; Rawnaq-Möllers T; Ghadban T
Sci Rep; 2021 Jul; 11(1):14616. PubMed ID: 34272441
[TBL] [Abstract][Full Text] [Related]
3. Circulating midkine in malignant and non-malignant colorectal diseases.
Krzystek-Korpacka M; Diakowska D; Neubauer K; Gamian A
Cytokine; 2013 Oct; 64(1):158-64. PubMed ID: 23899719
[TBL] [Abstract][Full Text] [Related]
4. Preoperative serum carbohydrate antigen 125 level is an independent negative prognostic marker for overall survival in colorectal cancer.
Yang XQ; Li Y; Chen C; Peng CW; Liu SP; Liu Y
Med Oncol; 2011 Sep; 28(3):789-95. PubMed ID: 20373053
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
Zhang SY; Lin M; Zhang HB
Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
[TBL] [Abstract][Full Text] [Related]
6. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.
Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z
Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815
[TBL] [Abstract][Full Text] [Related]
7. The utility and prognostic value of CA 19-9 and CEA serum markers in the long-term follow up of patients with colorectal cancer. A single-center experience over 13 years.
Tumay V; Guner OS
Ann Ital Chir; 2020; 91():494-503. PubMed ID: 32990277
[TBL] [Abstract][Full Text] [Related]
8. Preoperative serum midkine concentration is a prognostic marker for esophageal squamous cell carcinoma.
Shimada H; Nabeya Y; Tagawa M; Okazumi S; Matsubara H; Kadomatsu K; Muramatsu T; Ikematsu S; Sakuma S; Ochiai T
Cancer Sci; 2003 Jul; 94(7):628-32. PubMed ID: 12841873
[TBL] [Abstract][Full Text] [Related]
9. Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer.
Song YF; Xu ZB; Zhu XJ; Tao X; Liu JL; Gao FL; Wu CL; Song B; Lin Q
Clin Transl Oncol; 2017 Apr; 19(4):519-524. PubMed ID: 27743169
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer.
Kwon KA; Kim SH; Oh SY; Lee S; Han JY; Kim KH; Goh RY; Choi HJ; Park KJ; Roh MS; Kim HJ; Kwon HC; Lee JH
BMC Cancer; 2010 May; 10():203. PubMed ID: 20465852
[TBL] [Abstract][Full Text] [Related]
11. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
12. A prognostic model for colorectal cancer based on CEA and a 48-multiplex serum biomarker panel.
Björkman K; Jalkanen S; Salmi M; Mustonen H; Kaprio T; Kekki H; Pettersson K; Böckelman C; Haglund C
Sci Rep; 2021 Feb; 11(1):4287. PubMed ID: 33619304
[TBL] [Abstract][Full Text] [Related]
13. The effectiveness of serum midkine in detecting esophageal squamous cell carcinoma.
Shiratori F; Ito M; Yajima S; Suzuki T; Oshima Y; Nanami T; Funahashi K; Shimada H
Esophagus; 2019 Jul; 16(3):246-251. PubMed ID: 30778774
[TBL] [Abstract][Full Text] [Related]
14. Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer.
Abdel Ghafar MT; Gharib F; Abdel-Salam S; Elkhouly RA; Elshora A; Shalaby KH; El-Guindy D; El-Rashidy MA; Soliman NA; Abu-Elenin MM; Allam AA
Mol Biol Rep; 2020 Apr; 47(4):2509-2519. PubMed ID: 32088817
[TBL] [Abstract][Full Text] [Related]
15. Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients.
Gaber A; Nodin B; Hotakainen K; Nilsson E; Stenman UH; Bjartell A; Birgisson H; Jirström K
BMC Cancer; 2010 Sep; 10():498. PubMed ID: 20849596
[TBL] [Abstract][Full Text] [Related]
16. Preoperative serum carcinoembryonic antigen, carbohydrate antigen19-9 and carbohydrate antigen 125 as prognostic factors for recurrence-free survival in colorectal cancer.
Yang XQ; Chen C; Wang FB; Peng CW; Li Y
Asian Pac J Cancer Prev; 2011; 12(5):1251-6. PubMed ID: 21875276
[TBL] [Abstract][Full Text] [Related]
17. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
Wu F; Chen L; Wu W; Jiang B; Su X
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
[TBL] [Abstract][Full Text] [Related]
18. A Prospective Study of Comparing Multi-Gene Biomarker Chip and Serum Carcinoembryonic Antigen in the Postoperative Surveillance for Patients with Stage I-III Colorectal Cancer.
Chang YT; Huang MY; Yeh YS; Huang CW; Tsai HL; Cheng TL; Wang JY
PLoS One; 2016; 11(10):e0163264. PubMed ID: 27701415
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of carcinoembryonic antigen and carbohydrate antigen 19-9 in stage IV colorectal cancer patients after R0 resection.
Abe S; Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Tanaka T; Watanabe T
J Surg Res; 2016 Oct; 205(2):384-392. PubMed ID: 27664887
[TBL] [Abstract][Full Text] [Related]
20. Identification of Serum Periostin as a Potential Diagnostic and Prognostic Marker for Colorectal Cancer.
Dong D; Zhang L; Jia L; Ji W; Wang Z; Ren L; Niu R; Zhou Y
Clin Lab; 2018 Jun; 64(6):973-981. PubMed ID: 29945311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
